HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Contribution of the ATP binding site of ParE to susceptibility to novobiocin and quinolones in Streptococcus pneumoniae.

Abstract
In Streptococcus pneumoniae, an H103Y substitution in the ATP binding site of the ParE subunit of topoisomerase IV was shown to confer quinolone resistance and hypersensitivity to novobiocin when associated with an S84F change in the A subunit of DNA gyrase. We reconstituted in vitro the wild-type topoisomerase IV and its ParE mutant. The ParE mutant enzyme showed a decreased activity for decatenation at subsaturating ATP levels and was more sensitive to inhibition by novobiocin but was as sensitive to quinolones. These results show that the ParE alteration H103Y alone is not responsible for quinolone resistance and agree with the assumption that it facilitates the open conformation of the ATP binding site that would lead to novobiocin hypersensitivity and to a higher requirement of ATP.
AuthorsPhilippe Dupont, Alexandra Aubry, Emmanuelle Cambau, Laurent Gutmann
JournalJournal of bacteriology (J Bacteriol) Vol. 187 Issue 4 Pg. 1536-40 (Feb 2005) ISSN: 0021-9193 [Print] United States
PMID15687222 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Quinolones
  • Novobiocin
  • Adenosine Triphosphate
  • DNA Topoisomerase IV
  • DNA Gyrase
Topics
  • Adenosine Triphosphate (metabolism)
  • Amino Acid Substitution
  • Anti-Bacterial Agents (pharmacology)
  • Binding Sites
  • DNA Gyrase (genetics, metabolism)
  • DNA Topoisomerase IV (chemistry, genetics, isolation & purification, metabolism)
  • Drug Resistance, Bacterial (genetics)
  • Mutation
  • Novobiocin (pharmacology)
  • Protein Structure, Tertiary
  • Quinolones (pharmacology)
  • Streptococcus pneumoniae (drug effects, enzymology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: